£80 M Challenge For Faster, Better Dementia Diagnosis Launched

TL;DR

Prime Big Deal Days · Oct 6–7Offer from Amazon

Get health and wellness essentials delivered free — and shop member deals

• Fast, free delivery on millions of items
• Access to Prime Big Deal Days deals on October 6–7
• Prime Video, Amazon Music and more included

Start your free Prime trial →Free trial for eligible customers · Cancel anytime

As an affiliate, we earn on qualifying purchases.Hide

The UK government has launched an up-to-£80 million challenge to test nine approaches to faster and more accurate dementia diagnosis in the NHS. The stated target is for 92% of people referred to be diagnosed within 18 weeks, compared with about 60% currently; further challenge funding will depend on real-world results.

The UK government has launched an up-to-£80 million Dementia Challenge to test nine diagnostic technologies and service changes in the NHS, with a goal of diagnosing 92% of people within 18 weeks of referral. The programme aims to improve on the current rate of about 60%, while requiring projects to demonstrate their value in real-world NHS settings before they can receive further challenge funding.

The selected projects include efforts to shorten MRI brain scans, offer remote cognitive assessments and use blood-based biomarkers to support diagnosis. Other teams will test home monitoring, digital tools that measure how the brain processes sound, and clinical software that analyses routinely collected health information. A separate project will redesign dementia diagnosis and treatment services in Scotland.

The challenge is funded by the UK government through UK Research and Innovation’s Research and Development Missions Accelerator Programme. UKRI says the projects will undergo testing in the NHS and that only those shown to work will progress to further funding. The source announcement does not provide a breakdown of the overall £80 million between projects or specify how much each project will receive at this stage.

The programme is intended to help patients and families receive an earlier, more accurate diagnosis and better understand what it means for their lives. The government also says earlier diagnosis may allow people to access treatment sooner and make informed decisions about care, work, finances and family life. Those are expected benefits, not outcomes established by the launch announcement.

The Target for Faster Diagnosis

The challenge addresses a gap between the stated diagnosis target and current performance: about 60% of people are diagnosed within 18 weeks of referral, while the programme aims to reach 92%. The source report says diagnosis can often take more than a year, although it gives no further breakdown of waiting times by location or patient group.

Faster, more accurate assessment could affect when people and families can plan for support and care. The government says earlier diagnosis may also reduce emergency hospital admissions and delay the need for more intensive care support, potentially easing pressure on NHS services. These are aims of the programme; the selected projects still need to be evaluated to determine whether they deliver those effects.

The approach places several different methods into NHS testing rather than committing to one diagnostic tool. Requiring evidence of effectiveness before additional funding is intended to direct later support towards projects that show benefit for patients. Whether the technologies can be adopted consistently across services, and how much they could improve waiting times, remain matters for testing.

Nine Projects Enter NHS Testing

The nine selected projects cover changes to both diagnostic tools and service delivery. University College London and the UK Dementia Research Institute are studying whether MRI scan times can be cut from about 20 minutes to around seven minutes. The University of Exeter is integrating a digital platform to help people monitor cognitive changes and be assessed at an appropriate time.

Researchers at Imperial College London’s UK Dementia Research Institute Care Research & Technology Centre are developing Minder, a home-monitoring platform using unobtrusive sensors and linked artificial intelligence. The University of Oxford and Dementias Platform UK plan to bring a panel of blood-based biomarkers, validated in the READ-OUT study, into routine NHS memory services. Cognitron is testing a 15-minute remote digital cognitive assessment.

The other projects include sleep apnoea screening at the University of Bristol; a digital tool from Queen Mary University of London that assesses how the brain processes sound; an AI-enabled clinical decision-support tool from the University of Cambridge; and a service redesign project involving the University of Edinburgh and NHS Research Scotland. UKRI’s Health Mission is focusing on dementia first. The source report says more than 72,000 people across the UK died from dementia, including Alzheimer’s disease, in 2025, accounting for almost one in eight deaths.

Results and Funding Still Pending

The launch announcement does not set out the testing timetable, the evaluation criteria for each project, or the amount of funding allocated to individual teams. It also does not say when the 92% target is expected to be met or how progress towards it will be measured.

The technologies and service changes have been selected for real-world testing, but the announcement does not establish that any one approach is accurate, cost-effective or ready for routine use. Further funding is conditional on projects proving they work. The scale of any eventual improvement in diagnosis times, patient outcomes or NHS demand therefore remains unknown.

The announcement also does not explain how projects will be compared or whether all nine will be tested in the same settings. Details on implementation, patient participation and the results of the trials have not yet been provided in the source material.

Evidence Will Guide Further Funding

The next stage is real-world testing in the NHS. The projects will need to produce evidence that their approach works before they can receive additional challenge funding, according to the programme description. UKRI is working with partners across industry, academia, the NHS and health regulators and assessment bodies to develop and test innovations for NHS and social care use.

Further announcements are expected to clarify when individual tests begin, how their performance will be assessed and which projects progress to later funding. The central measure set out at launch is whether the programme can move the share of referrals diagnosed within 18 weeks from about 60% towards its 92% goal. No results or timetable for reaching that goal were included in the announcement.

Key Questions

What is the Dementia Challenge?

It is a UK government-backed programme worth up to £80 million to test nine technologies and service changes intended to speed up and improve dementia diagnosis in the NHS.

What diagnosis target has been set?

The stated goal is for 92% of people to receive a diagnosis within 18 weeks of referral. The source report puts the current share at about 60%.

What kinds of projects will be tested?

Projects include shorter MRI scans, blood-based biomarkers, remote cognitive assessments, home monitoring, sound-processing tests, AI-enabled clinical support and changes to Scotland’s diagnostic services.

Will all nine projects receive more funding?

Not necessarily. The announcement says further challenge funding depends on projects proving they work in real-world testing. It does not specify the assessment timetable or funding amounts for each team.

When will the projects begin, and when will results be available?

The source announcement says the projects will undergo NHS testing but gives no start dates or results schedule. Those details remain unclear.

Source: rss